We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.58%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.71B
AUM Growth
+$1.55B
Cap. Flow
+$1.78B
Cap. Flow %
18.36%
Top 10 Hldgs %
15.65%
Holding
829
New
260
Increased
164
Reduced
136
Closed
261

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$495M
2
GD icon
General Dynamics
GD
+$178M
3
AMZN icon
Amazon
AMZN
+$130M
4
WWD icon
Woodward
WWD
+$102M
5
LRCX icon
Lam Research
LRCX
+$97.7M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$588M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$111M
3
BDX icon
Becton Dickinson
BDX
+$99.6M
4
NOC icon
Northrop Grumman
NOC
+$86.6M
5
ROST icon
Ross Stores
ROST
+$76.7M

Sector Composition

Rank Sector Weight
1 Financials 19.29%
2 Technology 17.35%
3 Industrials 13.36%
4 Healthcare 11.97%
5 Consumer Discretionary 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MD icon
551
Pediatrix Medical
MD
$2.16B
$157K ﹤0.01%
+10,811
New +$154K
HAPN
552
Happen Inc
HAPN
$2.08B
$152K ﹤0.01%
+14,771
New +$198K
CDE icon
553
Coeur Mining
CDE
$15.6B
$146K ﹤0.01%
24,731
+13,318
+117% +$82.2K
EOLS icon
554
Evolus
EOLS
$394M
$137K ﹤0.01%
11,367
-1,314
-10% -$17.2K
KURA icon
555
Kura Oncology
KURA
$922M
$130K ﹤0.01%
+19,682
New +$153K
VSTS icon
556
Vestis
VSTS
$2.06B
$128K ﹤0.01%
+12,903
New +$171K
BCRX icon
557
BioCryst Pharmaceuticals
BCRX
$2.37B
$111K ﹤0.01%
14,735
-15,578
-51% -$126K
PUMP icon
558
ProPetro Holding
PUMP
$1.45B
$106K ﹤0.01%
14,414
+2,443
+20% +$21.2K
DNUT icon
559
Krispy Kreme
DNUT
$543M
$103K ﹤0.01%
+20,872
New +$159K
COGT icon
560
Cogent Biosciences
COGT
$6.79B
$98.9K ﹤0.01%
16,511
-15,682
-49% -$123K
STOK icon
561
Stoke Therapeutics
STOK
$1.82B
$98.3K ﹤0.01%
14,776
-3,273
-18% -$30.5K
NVAX icon
562
Novavax
NVAX
$1.23B
$90.3K ﹤0.01%
14,091
-34,590
-71% -$286K
BKD icon
563
Brookdale Senior Living
BKD
$3.62B
$80.5K ﹤0.01%
12,858
– –
ARDX icon
564
Ardelyx
ARDX
$1.24B
$78.9K ﹤0.01%
16,061
-270
-2% -$1.45K
QS icon
565
QuantumScape Corp
QS
$3B
$65.3K ﹤0.01%
+15,689
New +$77.6K
HBI
566
DELISTED
Hanesbrands
HBI
$62.3K ﹤0.01%
+10,801
New +$75.7K
FIP icon
567
FTAI Infrastructure
FIP
$500M
$57K ﹤0.01%
12,577
-5,005
-28% -$31.3K
IOVA icon
568
Iovance Biotherapeutics
IOVA
$2.23B
$51.5K ﹤0.01%
+15,480
New +$79.8K
AA icon
569
Alcoa
AA
$11.7B
– –
-7,437
Closed -$281K
AAP icon
570
Advance Auto Parts
AAP
$3.37B
– –
-136,684
Closed -$6.46M
ABBV icon
571
AbbVie
ABBV
$458B
– –
-7,601
Closed -$1.35M
ACHC icon
572
Acadia Healthcare
ACHC
$3.17B
– –
-755,178
Closed -$29.9M
ADI icon
573
Analog Devices
ADI
$181B
– –
-48,064
Closed -$10.2M
ADMA icon
574
ADMA Biologics
ADMA
$1.92B
– –
-44,816
Closed -$769K
ADP icon
575
Automatic Data Processing
ADP
$100B
– –
-34,711
Closed -$10.2M
21 22
23
24 25

Similar funds

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Freestone Grove Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Freestone Grove Partners held 829 positions worth $9.71B, up 19% from $8.16B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Freestone Grove Partners deployed $1.78B of net new capital in Q1 2025, opening 260 new positions and adding to 164 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 915,148 shares worth $470M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $588M trimmed.

  • Freestone Grove Partners's largest Q1 2025 buy was Vanguard S&P 500 ETF: 915,148 shares worth $470M.
  • Freestone Grove Partners added most to Lam Research in Q1 2025, an estimated $97.7M increase.
  • Freestone Grove Partners's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $588M.
  • Freestone Grove Partners fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $111M.
  • Freestone Grove Partners's ten largest holdings make up 16% of its $9.71B portfolio in Q1 2025.
  • Freestone Grove Partners opened 260 new positions and closed 261 in Q1 2025.
  • Freestone Grove Partners's portfolio value rose 19% quarter-over-quarter to $9.71B.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.